NASDAQ:CLLS

Cellectis S.a Stock Forecast

etoro logo Buy CLLS
*Your capital is at risk
$2.99
-0.183 (-5.77%)
At Close: Jul 10, 2026
AI Analysis AI Analysis of CLLS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CLLS to Watchlist?
Some Reasons Why To Add CLLS:
  • +88.1% price growth over the last year
  • High gross margin of 78.9%
  • Highly efficient cash conversion (106% FCF/OCF ratio)
PDF

Cellectis S.A. stock price fell more than -5.77% Friday closing at $2.99
(Updated on Jul 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 07, 2026 Loss -7.14%

The Cellectis S.A. stock price fell by -5.77% on the last day (Friday, 10th Jul 2026) from $3.17 to $2.99. During the last trading day the stock fluctuated 3.04% from a day low at $2.96 to a day high of $3.05. The price has fallen in 6 of the last 10 days but is still up by 3.46% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 thousand shares and in total, 6 thousand shares were bought and sold for approximately $18.31 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -30.70% during the next 3 months and, with a 90% probability hold a price between $1.76 and $2.22 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CLLS Signals & Forecast

There are mixed signals in the stock today. The Cellectis S.A. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.14 and $3.17. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Wednesday, June 24, 2026, and so far it has risen 7.17%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Cellectis S.A. stock

Cellectis S.A. finds support from accumulated volume at $2.98 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0900 between high and low, or 3.04%. For the last week the stock has had daily average volatility of 3.43%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CLLS) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Cellectis S.A. to open at $3.00, and during the day (based on 14 day Average True Range), to move between $2.89 and $3.09, which gives a possible trading interval of +/-$0.193 (+/-6.67%) up or down from last closing price. If Cellectis S.A. takes out the full calculated possible swing range there will be an estimated 6.67% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.98 (0.33%) than the resistance at $3.09 (3.34%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cellectis S.A. stock A Buy?

Cellectis S.A. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.588 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $3.00 ( 0.334%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CLLS Performance

Trading levels for CLLS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.09 3.34%
R2 3.06 2.19%
R1 3.03 1.48%
Price 2.99
S1 2.97 -0.82%
S2 2.94 -1.53%
S3 2.91 -2.68%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.63 21.40%
R2 3.18 6.35%
R1 3.09 3.34%
Price 2.99
S1 2.98 -0.334%
S2 2.93 -2.01%
S3 2.89 -3.34%

FAQ

What is the symbol for Cellectis S.A. Stock and on which exchange is it traded?
The symbol for Cellectis S.A. is CLLS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cellectis S.A. Stock?
Cellectis S.A. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Cellectis S.A. Stock?
Cellectis S.A. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cellectis S.A. Stock.

What's the current price of Cellectis S.A. Stock?
As of the end of day on the Jul 10, 2026, the price of an Cellectis S.A. (CLLS) share was $2.99.

What is the 52-week high and low for Cellectis S.A. Stock?
The 52-week high for Cellectis S.A. Stock is $5.48 and the 52-week low is $1.59.

What is the market capitalization of Cellectis S.A. Stock?
As of the Jul 10, 2026, the market capitalization of Cellectis S.A. is 300.247M.

When is the next earnings date for Cellectis S.A.?
The upcoming earnings date for Cellectis S.A. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT CELLECTIS S.A.
Cellectis S.A
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE